DMAC

DMAC R&D to Revenue

0.00%Fiscal year

Period ending:

DMAC FY R&D/Revenue%
DMAC FY R&D/Revenue2686.12%-287.80%
2004-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

DMAC r&d to revenue history

R&D spending as percentage of revenue. The available annual fiscal periods series contains 22 observations from Dec 31, 2004 to Dec 31, 2025.

Diamedica Therapeutics Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
0%
0%
0%
0%
0%
0%
0%
904.4%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
664.3986%
2,398.3254%
88.5977%
1,363.5843%

Compare r&d to revenue

All DMAC financial metrics · DMAC stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.